Telix Pharmaceuticals Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Telix Pharmaceuticals Ltd's ROI in the fourth quarter of 2025?
Telix Pharmaceuticals Ltd recorded a cumulative net loss of $-7 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -0.97%.

Within the Healthcare sector 255 other companies had a higher return on investment. While the total ranking for ROI remained the same, compared to the third quarter of 2025 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Investment Change TTM	-9.9 %	-10.58 %	41.19 %	186.07 %	2913.6 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	621	772	772	772	367
Return On Investment (TTM)	-0.97 %	7.45 %	6.95 %	6.51 %	6.13 %
TLX's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	9.47 %	-6.69 %	-6.27 %	-5.9 %	8.64 %
Seq. Net Income Change TTM	-	0 %	0 %	0 %	-
Net Income (TTM) in Millions	-7	50	50	50	50

TLX Company Profile >> Back to TLX Roi Comparisons >> See Annual TLX Return On Investment

Return On Investment TLX's Ranking
Within:	No.
Industry	# 90
Sector	# 256
Overall	#

Return On Investment Statistics
High	Average	Low
-1.51 %	-1.51 %	-1.51 %
(Dec 31 2025)

Financial Statements
Telix Pharmaceuticals Ltd's IV. Quarter Investments	$ 621 Millions	TLX's Balance sheet
Telix Pharmaceuticals Ltd's IV. Quarter Income	$ -7 Millions	Quarterly TLX's Income Statement
TLX's Income by Division		See TLX's Income by Division

TLX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	473	367	0	0	0
Y / Y Investment Growth	28.73 %	-	-	-	-
Net Income in Millions	-7	34	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-1.51 %	9.17 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TLX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TLX's Competitors
Subscribers only: Roi for Telix Pharmaceuticals Ltd's Suppliers
Subscribers only: Return On Investment for TLX's Customers

Other Ratios
TLX's Roa	TLX's Inventory Turnover Ratio	TLX's Growth Rates	TLX's Dividend Statistics
	TLX's Profitability Ratios	TLX's Asset Turnover Ratio	TLX's Dividend Growth
TLX's Roe	TLX's Valuation Ratios	TLX's Financial Strength Ratios	TLX's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-07-07T14:04:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.